REIT & Securities
Verified Update
Ruling Issued
A federal judge dismissed without prejudice a securities class action against Alexandria Real Estate Equities over $2.2 billion in life-science impairments, finding intent not adequately alleged.
U.S. District Judge George Wu dismissed, without prejudice, a proposed securities class action accusing Alexandria Real Estate Equities and three of its executives of misleading investors about the strength of its life-science leasing pipeline, including a Long Island City, Queens property that took a roughly $206 million impairment. The court found lead plaintiff Warren Hern's complaint did not adequately allege that Alexandria's executives acted with the intent or severe recklessness securities-fraud law requires.
Putative class action tied to $2.2 billion in life-science property impairments recognized during the class period; dismissed without prejudice
Life Sciences
Why it matters: Confirms that a large impairment charge or guidance cut, standing alone, does not satisfy the Private Securities Litigation Reform Act's heightened scienter-pleading standard, giving REITs a meaningful defense against shareholder suits filed reflexively after a stock-price decline. Life-science and lab-space REITs facing softer post-pandemic demand should expect continued plaintiffs'-bar scrutiny of leasing-pipeline disclosures even as this ruling raises the bar for such claims to survive a motion to dismiss.
Sep 8, 2026
U.S. District Court for the Central District of California
Commercial Lease Disputes
Verified Update
Pending
Alexandria Real Estate Equities is suing NYC Health + Hospitals and the city's Economic Development Corporation to stop them from terminating its option to expand its Manhattan life-science megacampus, after sinking $185.9 million into pre-construction costs.
Alexandria Real Estate Equities disclosed in its October 26, 2026 quarterly SEC filing that it remains in litigation with the New York City Health + Hospitals Corporation and the New York City Economic Development Corporation over its option, granted in 2006, to incorporate an adjacent parcel into the ground lease for its Alexandria Center for Life Science megacampus in Manhattan. After suing in the Southern District of New York in 2024 and amending that complaint in January 2025 to add fraud and breach-of-contract claims, Alexandria filed a second action in the Commercial Division of the New York State Supreme Court on May 12, 2026, seeking a Yellowstone injunction and other emergency relief to stop the agencies from terminating the option over an alleged, disputed default.
$185.9 million in pre-construction costs tied to the disputed ground-lease option; default notice threatens escalating $1,000-$2,000/day charges
Why it matters: Alexandria's $185.9 million in pre-construction spending on the option illustrates how much capital a sophisticated developer can commit toward an unbuilt expansion before the underlying right to build is finally resolved, and how a government landlord's default notice can turn a contract dispute into an existential threat to that investment. The Yellowstone injunction fight is a live example of the tool New York commercial tenants use to freeze cure-period deadlines while a landlord dispute is litigated, relevant to any owner or tenant holding options or expansion rights under a ground lease with a public agency.
May 12, 2026
Supreme Court of the State of New York, New York County (Commercial Division)
